AI assistant
AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2014
Mar 7, 2014
31580_dirs_2014-03-07_a91f3a6b-6e07-4295-93e5-5abdc430a718.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2014-03-05
Reporting Person: Higgons John Duncan (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-06 | Common stock | M | 5646 | $0.3025 | Acquired | 114736 | Direct |
| 2014-03-06 | Common stock | S | 5646 | $35.54 | Disposed | 109090 | Direct |
| 2014-03-07 | Common stock | M | 9000 | $0.3025 | Acquired | 118090 | Direct |
| 2014-03-07 | Common stock | S | 9000 | $45.10 | Disposed | 109090 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-03-05 | Stock option (right to buy) | $31.64 | A | 80000 | Acquired | 2024-03-04 | Common Stock (80000) | Direct |
| 2014-03-06 | Stock option (right to buy) | $0.3025 | M | 5646 | Disposed | 2019-08-12 | Common stock (5646) | Direct |
| 2014-03-07 | Stock option (right to buy) | $0.3025 | M | 9000 | Disposed | 2019-08-12 | Common stock (9000) | Direct |
Footnotes
F1: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $35.00 to $36.86. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $45.00 to $46.45. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F5: This option was granted on March 5, 2014. The shares underlying this option vest as to 25% of the underlying shares on March 5, 2015, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F6: This option was granted on August 13, 2009. The shares underlying this option vest as to 25% of the underlying shares on May 18, 2010, with the remaining 75% vesting in 36 equal monthly installments thereafter.